Related Experiment Video

Updated: Aug 23, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma

Koichiro Muta1, Koichi Ohshima, Yasunobu Abe

  • 1Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan. mmmmm@intmed3.med.kyushu-u.ac.jp

International Journal of Hematology
|June 29, 2004
PubMed

Insights

Receptor-binding cancer antigen 1 (RCAS1) expression is linked to immune evasion in adult T-cell leukemia/lymphoma (ATLL). High RCAS1 levels in ATLL patients may predict a poorer prognosis, aiding in immune surveillance evasion.

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • Receptor-binding cancer antigen 1 (RCAS1) on tumor cells can induce apoptosis in immune cells, facilitating immune evasion.
  • Adult T-cell leukemia/lymphoma (ATLL) is associated with human T-lymphotropic virus type I (HTLV-1) infection.

Purpose of the Study:

  • To investigate the expression of RCAS1 in ATLL patient lymph node specimens.
  • To determine the association between RCAS1 expression and prognosis in ATLL.
  • To compare RCAS1 expression in ATLL with B-cell lymphomas.

Main Methods:

  • Immunohistochemical analysis of RCAS1 expression in lymph node biopsies.
  • Correlation of RCAS1 staining intensity with patient survival data.
  • Comparison of RCAS1 expression between ATLL and B-cell lymphoma cases.

Main Results:

  • RCAS1 expression was detected in 75% (15/20) of ATLL cases.
  • All ATLL cases with short survival times showed positive RCAS1 staining.
  • Only 13% (1/8) of B-cell lymphoma cases exhibited positive RCAS1 staining.

Conclusions:

  • RCAS1 expression is significantly associated with ATLL.
  • RCAS1 may play a role in immune evasion in HTLV-1-infected cells, contributing to leukemia/lymphoma development.
  • RCAS1 expression levels could serve as a prognostic marker for ATLL patients.

More Related Videos

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...